Should You Invest In GW Pharmaceuticals Plc?

Get the facts about trading GW Pharmaceuticals Plc before you start. Discuss investment strategies, review market research, and get real-time updates

621,176 GW Pharmaceuticals Plc positions opened on eToro

Buy GWPH
Sell GWPH
GWPHGW Pharmaceuticals Plc
219.090.03 ( 0.01%)
124.84 (-1.12%)
2304.83 (-0.77%)
309.90 (-1.74%)
242.99 (-0.86%)
53.19 (1.12%)

GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, UK. It is a biopharmaceutical company, which is currently focused on developing and marketing cannabinoid-based medicines for a range of disease areas. Key products include Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD), and Sativex (nabiximols), which is used for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Follow the GWPH instrument to learn all about the latest news and developments.

Buy GWPH Now
Sell GWPH Now

Historical Price Charts

Discover the eToro Advantage

Use eToro's advanced risk management tools to protect your positions. Enjoy hassle-free deposits and withdrawals, instant execution of trades and a free $100,000 demo account to practice your strategy.

Volatility means opportunity! Watch price changes reflect directly onto your portfolio

Start trading within minutes - no physical purcase delays

Benefit from falling prices as well as rising prices. Buy or sell instantly

关注我们

微信公众号: e投睿eToro

Start Trading
got it